79 related articles for article (PubMed ID: 8310771)
1. [Anticoagulation after arterial reconstruction in peripheral arterial occlusive disease (observations over more than 15 years)].
Waibel P
Vasa; 1993; 22(4):320-9. PubMed ID: 8310771
[TBL] [Abstract][Full Text] [Related]
2. [Combined arterial bypass operation and coumarin therapy--a concept for long-term management and its conditions].
Kühnel L; Heinrichs C; Wache I; Neugebauer J
Vasa Suppl; 1991; 32():509-12. PubMed ID: 1771568
[TBL] [Abstract][Full Text] [Related]
3. Optimal oral anticoagulant therapy in patients with mechanical heart valves.
Cannegieter SC; Rosendaal FR; Wintzen AR; van der Meer FJ; Vandenbroucke JP; Briët E
N Engl J Med; 1995 Jul; 333(1):11-7. PubMed ID: 7776988
[TBL] [Abstract][Full Text] [Related]
4. [Endovascular therapy in combination with conventional vascular surgery for the treatment of peripheral arterial obliterative disease].
Gassel HJ; Kellersmann R; Franke S; Thiede A
Zentralbl Chir; 2002 Feb; 127(2):99-104. PubMed ID: 11894210
[TBL] [Abstract][Full Text] [Related]
5. [Laser angioplasty combined with balloon dilatation in chronic peripheral arterial occlusive disease--long-term results after 3 years].
Pilger E; Lammer J; Stark G; Decrinis M; Obernosterer A; Lafer M; Pieber D; Rumpl F
Vasa Suppl; 1990; 30():191-3. PubMed ID: 2150127
[No Abstract] [Full Text] [Related]
6. [Differences in the prognosis of arterial reconstruction in stage II and IV peripheral arterial disease. Results of a minimum of 15 to 25 years follow-up].
Waibel P
Vasa; 1992; 21(1):46-51. PubMed ID: 1580090
[TBL] [Abstract][Full Text] [Related]
7. [17 years experience with saphenous vein in situ bypass].
Gruss JD; Hiemer W
Langenbecks Arch Chir Suppl Kongressbd; 1992; ():460-1. PubMed ID: 1493305
[TBL] [Abstract][Full Text] [Related]
8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
9. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions.
Taylor SM; Kalbaugh CA; Blackhurst DW; Cass AL; Trent EA; Langan EM; Youkey JR
J Vasc Surg; 2006 Oct; 44(4):747-55; discussion 755-6. PubMed ID: 16926083
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
11. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses.
Horstkotte D; Schulte H; Bircks W; Strauer B
J Heart Valve Dis; 1993 May; 2(3):291-301. PubMed ID: 8269122
[TBL] [Abstract][Full Text] [Related]
12. Effect of risk factors on outcome in patients with peripheral arterial occlusive disease.
von Knorring J; Lepäntalo M
Ann Chir Gynaecol; 1992; 81(2):103-6. PubMed ID: 1622059
[No Abstract] [Full Text] [Related]
13. The five-year results of reconstructive surgery for critical lower limb ischemia.
Burleva EP; Fokin AA
Angiol Sosud Khir; 2005; 11(3):115-22. PubMed ID: 16439957
[TBL] [Abstract][Full Text] [Related]
14. The overdosed patient and bleedings with oral anticoagulation.
Pindur G; Mörsdorf S; Schenk JF; Krischek B; Heinrich W; Wenzel E
Semin Thromb Hemost; 1999; 25(1):85-8. PubMed ID: 10327226
[TBL] [Abstract][Full Text] [Related]
15. [Revascularising osteotrepanation in treatment of lower limbs critical ischemia].
Zusmanovich FN
Khirurgiia (Mosk); 1999; (4):10-2. PubMed ID: 10234901
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of results for operative and conservative treatment of multisegmental atheromatous arterial occlusion in the lower limbs after a 2-year period of observation].
Głowiński S; Wołczyński Z; Lapiński R; Guzowski A
Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):690-3. PubMed ID: 1669133
[TBL] [Abstract][Full Text] [Related]
17. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.
Criado E; Burnham SJ; Tinsley EA; Johnson G; Keagy BA
J Vasc Surg; 1993 Sep; 18(3):495-504; discussion 504-5. PubMed ID: 8377244
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of obliterating arterial diseases of the extremities by a revascularizing osteotrepanation method].
Zusmanovich FN
Khirurgiia (Mosk); 1996; (6):34-6. PubMed ID: 9173146
[TBL] [Abstract][Full Text] [Related]
19. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
20. [Surgical measures in PTA--indications and results].
Raithel D
Langenbecks Arch Chir Suppl Kongressbd; 1991; ():529-33. PubMed ID: 1838948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
